Free Trial

Benitec Biopharma (BNTC) News Today

Benitec Biopharma logo
$10.68 +0.28 (+2.69%)
(As of 11/15/2024 ET)
Benitec Biopharma Inc. stock logo
Simplify Asset Management Inc. Grows Position in Benitec Biopharma Inc. (NASDAQ:BNTC)
Simplify Asset Management Inc. boosted its position in Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) by 127.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 116,535 shares of the biotechnology company's stock after purchasing an additional 65
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) saw a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 56,900 shares, an increase of 49.0% from the October 15th total of 38,200 shares. Based on an average daily trading volume, of 28,900 shares, the days-to-cover ratio is presently 2.0 days.
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of "Buy" from Analysts
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six ratings firms that are currently covering the company, Marketbeat reports. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating on the
Benitec Biopharma files $125M mixed securities shelf
Benitec Biopharma (BNTC) Receives a Buy from Piper Sandler
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) to Post Q1 2025 Earnings of ($0.54) Per Share, Leerink Partnrs Forecasts
Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Benitec Biopharma in a report released on Monday, October 14th. Leerink Partnrs analyst M. Foroohar anticipates that the biotechnology company will post earnings
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of "Buy" from Brokerages
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) has been given an average rating of "Buy" by the five research firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the comp
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Now Covered by Oppenheimer
Oppenheimer assumed coverage on shares of Benitec Biopharma in a research report on Wednesday. They issued an "outperform" rating and a $35.00 price target for the company.
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50 Day Moving Average - What's Next?
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50-Day Moving Average - Time to Sell?
Benitec Biopharma Inc. stock logo
Nantahala Capital Management LLC Buys New Shares in Benitec Biopharma Inc. (NASDAQ:BNTC)
Nantahala Capital Management LLC purchased a new stake in shares of Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 841,395 shares of the biot
Benitec Biopharma Inc. stock logo
JMP Securities Reiterates Market Outperform Rating for Benitec Biopharma (NASDAQ:BNTC)
JMP Securities reiterated a "market outperform" rating and issued a $16.00 target price on shares of Benitec Biopharma in a research note on Monday.
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Significant Decline in Short Interest
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 62,000 shares, a decrease of 6.8% from the August 15th total of 66,500 shares. Based on an average trading volume of 29,200 shares, the days-to-cover ratio is currently 2.1 days.
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Receives New Coverage from Analysts at Guggenheim
Guggenheim initiated coverage on shares of Benitec Biopharma in a research report on Thursday. They set a "buy" rating and a $17.00 price target for the company.
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Decline in Short Interest
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) saw a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 68,000 shares, a decrease of 18.2% from the July 15th total of 83,100 shares. Based on an average daily trading volume, of 37,100 shares, the days-to-cover ratio is presently 1.8 days.
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Shares Pass Above Fifty Day Moving Average of $8.25
Benitec Biopharma (NASDAQ:BNTC) Shares Pass Above 50 Day Moving Average of $8.25
Benitec Biopharma Inc. stock logo
Janus Henderson Group PLC Has $1.27 Million Stock Holdings in Benitec Biopharma Inc. (NASDAQ:BNTC)
Janus Henderson Group PLC lifted its position in Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) by 35.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 244,491 shares of the biotechnology company's stock after buyin
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. to Post FY2024 Earnings of ($5.45) Per Share, Leerink Partnrs Forecasts (NASDAQ:BNTC)
Benitec Biopharma Inc. (NASDAQ:BNTC - Free Report) - Leerink Partnrs issued their FY2024 earnings estimates for Benitec Biopharma in a research report issued on Monday, July 22nd. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will post earnings of ($5.45) per share
Benitec Biopharma Share Price (BNTC.US)
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at SVB Leerink
SVB Leerink started coverage on shares of Benitec Biopharma in a research note on Monday. They set an "outperform" rating and a $13.00 price objective for the company.
Benitec Biopharma Ltd ADR (BNTC)
Benitec Biopharma Inc. stock logo
Short Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Rises By 871.6%
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 92,300 shares, a growth of 871.6% from the June 15th total of 9,500 shares. Based on an average daily trading volume, of 97,700 shares, the short-interest ratio is presently 0.9 days. Approximately 4.1% of the company's stock are sold short.
Benitec Biopharma Inc. stock logo
Benitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Decrease in Short Interest
Benitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 9,500 shares, a decline of 25.8% from the May 31st total of 12,800 shares. Based on an average trading volume of 96,100 shares, the short-interest ratio is presently 0.1 days. Currently, 0.4% of the company's shares are short sold.
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Stock Passes Below 50 Day Moving Average of $7.93
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Below 50 Day Moving Average of $7.93
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Share Price Passes Below Fifty Day Moving Average of $7.76
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Below Fifty Day Moving Average of $7.76
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Shares Pass Below 50 Day Moving Average of $7.34
Benitec Biopharma (NASDAQ:BNTC) Stock Passes Below 50 Day Moving Average of $7.34
Benitec Biopharma Inc. stock logo
Benitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50 Day Moving Average of $6.50
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above Fifty Day Moving Average of $6.50
Get Benitec Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter.

My Top Trump Rally Stocks (Ad)

This Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.

Click here for details on your FREE RSVP.

BNTC Media Mentions By Week

BNTC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BNTC
News Sentiment

0.88

0.54

Average
Medical
News Sentiment

BNTC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BNTC Articles
This Week

7

1

BNTC Articles
Average Week

Get Benitec Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BNTC) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners